CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma

Soft tissue sarcoma (STS) is a heterogenous tumor arising from the embryonic mesoderm represented by approximately 50 histological subtypes. Effective therapeutic intervention is lacking for recurrent, late stage and metastatic disease. CD39, a cell-surface ectonucleotidase, has previously been show...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Transl Res
Autors principals: Hayes, Gregory M, Cairns, Belinda, Levashova, Zoia, Chinn, Lawrence, Perez, Myra, Theunissen, Jan-Willem, Liao-Chan, Sindy, Bermudez, Abel, Flory, Mark R, Schweighofer, Karl J, H van der Horst, Edward
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4532750/
https://ncbi.nlm.nih.gov/pubmed/26279761
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars